BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 34049675)

  • 1. Meta-Analysis Comparing the Effect of Combined Omega-3 + Statin Therapy Versus Statin Therapy Alone on Coronary Artery Plaques.
    Fan H; Zhou J; Yuan Z
    Am J Cardiol; 2021 Jul; 151():15-24. PubMed ID: 34049675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS.
    Hattori K; Ozaki Y; Ismail TF; Okumura M; Naruse H; Kan S; Ishikawa M; Kawai T; Ohta M; Kawai H; Hashimoto T; Takagi Y; Ishii J; Serruys PW; Narula J
    JACC Cardiovasc Imaging; 2012 Feb; 5(2):169-77. PubMed ID: 22340823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Statin Therapy on Fibrous Cap Thickness in Coronary Plaques Using Optical Coherence Tomography: A Systematic Review and Meta-Analysis.
    Zheng G; Chen J; Lin C; Huang X; Lin J
    J Interv Cardiol; 2015 Dec; 28(6):514-22. PubMed ID: 26487187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies.
    Banach M; Serban C; Sahebkar A; Mikhailidis DP; Ursoniu S; Ray KK; Rysz J; Toth PP; Muntner P; Mosteoru S; García-García HM; Hovingh GK; Kastelein JJ; Serruys PW;
    BMC Med; 2015 Sep; 13():229. PubMed ID: 26385210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of coronary plaque composition correlate with C-reactive protein levels in patients with ST-elevation myocardial infarction following high-intensity statin therapy.
    Koskinas KC; Zaugg S; Yamaji K; García-García HM; Taniwaki M; Klingenberg R; Moschovitis A; Lüscher TF; van Tits LJ; Matter CM; Windecker S; Räber L
    Atherosclerosis; 2016 Apr; 247():154-60. PubMed ID: 26921743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of combined ezetimibe and statin therapy versus statin therapy alone on coronary plaque volume assessed by intravascular ultrasound: A systematic review and meta-analysis.
    Mirzaee S; Thein PM; Nogic J; Nerlekar N; Nasis A; Brown AJ
    J Clin Lipidol; 2018; 12(5):1133-1140.e15. PubMed ID: 30318063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Eicosapentaenoic and Docosahexaenoic Acids Added to Statin Therapy on Coronary Artery Plaque in Patients With Coronary Artery Disease: A Randomized Clinical Trial.
    Alfaddagh A; Elajami TK; Ashfaque H; Saleh M; Bistrian BR; Welty FK
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29246960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Statin Therapy in Inducing Coronary Plaque Regression in Patients with Low Baseline Cholesterol Levels.
    Wakabayashi K; Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Miyake S; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Suzuki H; Michishita I;
    J Atheroscler Thromb; 2016 Sep; 23(9):1055-66. PubMed ID: 27040362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Statin Therapy on Fibrous Cap Thickness in Coronary Plaque on Optical Coherence Tomography - Review and Meta-Analysis.
    Ozaki Y; Garcia-Garcia HM; Beyene SS; Hideo-Kajita A; Kuku KO; Kolm P; Waksman R
    Circ J; 2019 Jun; 83(7):1480-1488. PubMed ID: 31118354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
    Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
    Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial.
    Räber L; Ueki Y; Otsuka T; Losdat S; Häner JD; Lonborg J; Fahrni G; Iglesias JF; van Geuns RJ; Ondracek AS; Radu Juul Jensen MD; Zanchin C; Stortecky S; Spirk D; Siontis GCM; Saleh L; Matter CM; Daemen J; Mach F; Heg D; Windecker S; Engstrøm T; Lang IM; Koskinas KC;
    JAMA; 2022 May; 327(18):1771-1781. PubMed ID: 35368058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of lipid and inflammatory profiles on the morphological changes of lipid-rich plaques in patients with non-ST-segment elevated acute coronary syndrome: follow-up study by optical coherence tomography and intravascular ultrasound.
    Takarada S; Imanishi T; Ishibashi K; Tanimoto T; Komukai K; Ino Y; Kitabata H; Kubo T; Tanaka A; Kimura K; Mizukoshi M; Akasaka T
    JACC Cardiovasc Interv; 2010 Jul; 3(7):766-72. PubMed ID: 20650439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive statin versus low-dose statin + ezetimibe treatment for fibrous cap thickness of coronary vulnerable plaques.
    Meng PN; Yin DL; Lu WQ; Xu T; You W; Wu ZM; Wu XQ; Ye F
    Chin Med J (Engl); 2020 Oct; 133(20):2415-2421. PubMed ID: 32889912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of statin therapy on the progression of coronary atherosclerosis.
    Tian J; Gu X; Sun Y; Ban X; Xiao Y; Hu S; Yu B
    BMC Cardiovasc Disord; 2012 Sep; 12():70. PubMed ID: 22938176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study.
    Räber L; Taniwaki M; Zaugg S; Kelbæk H; Roffi M; Holmvang L; Noble S; Pedrazzini G; Moschovitis A; Lüscher TF; Matter CM; Serruys PW; Jüni P; Garcia-Garcia HM; Windecker S;
    Eur Heart J; 2015 Feb; 36(8):490-500. PubMed ID: 25182248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study-Rationale and design of the PACMAN-AMI trial.
    Zanchin C; Koskinas KC; Ueki Y; Losdat S; Häner JD; Bär S; Otsuka T; Inderkum A; Jensen MRJ; Lonborg J; Fahrni G; Ondracek AS; Daemen J; van Geuns RJ; Iglesias JF; Matter CM; Spirk D; Juni P; Mach F; Heg D; Engstrom T; Lang I; Windecker S; Räber L
    Am Heart J; 2021 Aug; 238():33-44. PubMed ID: 33951415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN.
    Puri R; Libby P; Nissen SE; Wolski K; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Raichlen JS; Uno K; Kataoka Y; Tuzcu EM; Nicholls SJ
    Eur Heart J Cardiovasc Imaging; 2014 Apr; 15(4):380-8. PubMed ID: 24448227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is age an important factor for vascular response to statin therapy? A serial optical coherence tomography and intravascular ultrasound study.
    Dai J; Hou J; Xing L; Jia H; Hu S; Soeda T; Minami Y; Ong D; Vergallo R; Zhang S; Lee H; Yu B; Jang IK
    Coron Artery Dis; 2017 May; 28(3):209-217. PubMed ID: 28059849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Intensive Lipid-Lowering Therapy on Coronary Plaque Stabilization Derived from Optical Coherence Tomography: a Meta-analysis and Meta-regression.
    Liu S; Hou J; Wan J; Yang Y; Wang D; Liang D; Wang X; Zhou P; Wang P
    Cardiovasc Drugs Ther; 2023 Oct; ():. PubMed ID: 37815648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.